Financial statements Heliosz Med
Balance sheet data of HELIOSZ MED
|
Year
|
2022
|
2023
|
|---|---|---|
| Total assets | 2 707 637,15 | 3 667 014,97 |
| A. Fixed assets | 2 358 833,52 | 3 058 752,64 |
| B. Current assets | 348 803,63 | 608 262,33 |
| C. Share capital contributions (basic funds) | - | - |
| D. Own shares (stocks) | - | - |
| Total liabilities | 2 707 637,15 | 3 667 014,97 |
| A. Equity | 546 057,38 | 963 891,06 |
| B. Liabilities and provisions for liabilities | 2 161 579,77 | 2 703 123,91 |
| I. Long-term liabilities | 1 809 075,00 | 2 139 428,12 |
| II. Short-term liabilities | 352 504,77 | 563 695,79 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.